abstract |
The present invention relates to 4-((1R,3S)-6-chloro-3-phenyl-dihydroindol-1-yl)-1,2 which is active against dopamine D1 and D2 receptors and serotonin 5HT2 receptor. , 2-trimethyl-piperidin and its salts for the treatment of central nervous system disorders in a weekly dosing regimen. |